Literature DB >> 6345605

Bullous pemphigoid: a cause of peripheral blood eosinophilia.

L L Bushkell, R E Jordon.   

Abstract

A retrospective study demonstrated that fourteen of twenty-eight patients (50%) with clinical, histologic, and immunofluorescent findings of bullous pemphigoid had peripheral blood eosinophilia. Blood eosinophilia ranged from 5% to 43% when first tested, with increase in one patient to 56% during treatment. The pathophysiologic cause of blood eosinophilia in bullous pemphigoid is discussed with its relationship to previously demonstrated elevations of IgE and eosinophilic chemotactic factor of anaphylaxis (ECF-A) in serum and blister fluid. Peripheral blood eosinophilia was a common finding in our group of patients, and bullous pemphigoid should be included in the differential diagnosis of bullous skin conditions with eosinophilia.

Entities:  

Mesh:

Year:  1983        PMID: 6345605     DOI: 10.1016/s0190-9622(83)70073-3

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  10 in total

1.  Increased immunoreactive interleukin-5 levels in blister fluids of bullous pemphigoid.

Authors:  H Endo; I Iwamoto; M Fujita; S Okamoto; S Yoshida
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

Review 2.  Bullous pemphigoid: from bench to bedside.

Authors:  Scott R A Walsh; David Hogg; P Régine Mydlarski
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  Mechanisms of Disease: Pemphigus and Bullous Pemphigoid.

Authors:  Christoph M Hammers; John R Stanley
Journal:  Annu Rev Pathol       Date:  2016-02-22       Impact factor: 23.472

Review 4.  The pathophysiology of bullous pemphigoid.

Authors:  Michael Kasperkiewicz; Detlef Zillikens
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

Review 5.  Skin barrier disruption: a requirement for allergen sensitization?

Authors:  Anna De Benedetto; Akiharu Kubo; Lisa A Beck
Journal:  J Invest Dermatol       Date:  2012-01-05       Impact factor: 8.551

Review 6.  Eosinophils in Autoimmune Diseases.

Authors:  Nicola L Diny; Noel R Rose; Daniela Čiháková
Journal:  Front Immunol       Date:  2017-04-27       Impact factor: 7.561

Review 7.  The Intersection of IgE Autoantibodies and Eosinophilia in the Pathogenesis of Bullous Pemphigoid.

Authors:  Kelly N Messingham; Tyler P Crowe; Janet A Fairley
Journal:  Front Immunol       Date:  2019-10-04       Impact factor: 7.561

8.  Effects of Omalizumab on FcεRI and IgE Expression in Lesional Skin of Bullous Pemphigoid.

Authors:  S Morteza Seyed Jafari; Karolina Gadaldi; Laurence Feldmeyer; Nikhil Yawalkar; Luca Borradori; Christoph Schlapbach
Journal:  Front Immunol       Date:  2019-08-14       Impact factor: 7.561

Review 9.  IgE autoantibodies and their association with the disease activity and phenotype in bullous pemphigoid: a systematic review.

Authors:  Ariadne Hadjikyriacou Saniklidou; Patrick J Tighe; Lucy C Fairclough; Ian Todd
Journal:  Arch Dermatol Res       Date:  2017-10-25       Impact factor: 3.017

Review 10.  The Role of Eosinophils in Bullous Pemphigoid: A Developing Model of Eosinophil Pathogenicity in Mucocutaneous Disease.

Authors:  Kyle T Amber; Manuel Valdebran; Khalaf Kridin; Sergei A Grando
Journal:  Front Med (Lausanne)       Date:  2018-07-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.